Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses [clinicaltrials:NCT00024687]
Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses [clinicaltrials:NCT00024687]
Bio2RDF identifier
NCT00024687
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00024687
identifiers.org URI
actual enrollment [clinicaltrials_vocabulary:actual-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
Although Neopharm has t ...... g toxicity (DLT) is observed.
brief title [clinicaltrials_vocabulary:brief-title]
Study of SS1(dsFv)-PE38 (SS1P) ...... s: IV Infusion QOD x Six Doses
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES: I. Determin ...... ED ACCRUAL: Up to 30 patients
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2001-09-24T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
SS1(dsFv)-PE38 Anti-Mesothelin Immunotoxin
advanced malignancy
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2014-11-13T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00024687
org study id [clinicaltrials_vocabulary:org-study-id]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2000-11-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2014-11-01T00:00:00Z
why stopped [clinicaltrials_vocabulary:why-stopped]
Support withdrawn - Study continued by NCI - see record NCT00006981
identifier
clinicaltrials:NCT00024687
title
Study of SS1(dsFv)-PE38 (SS1P) ...... s: IV Infusion QOD x Six Doses
@en
type
label
Study of SS1(dsFv)-PE38 (SS1P) ...... s [clinicaltrials:NCT00024687]
@en